Investing.com - Boston Scientific (NYSE:BSX) reported on Wednesday fourth quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Boston Scientific announced earnings per share of $0.23 on revenue of $2.71B. Analysts polled by Investing.com anticipated EPS of $0.3132 on revenue of $2.83B.
Boston Scientific shares are up 1.92% from the beginning of the year and are trading at $36.64 , down-from-52-week-high.They are broadly in line with the S&P 500 which is up 1.87% from the start of the year.
Boston Scientific follows other major Healthcare sector earnings this month
Boston Scientific's report follows an earnings beat by J&J on Tuesday, January 26, 2021, who reported EPS of $1.86 on revenue of $22.48B, compared to forecasts EPS of $1.82 on revenue of $21.66B.
Abbott Labs had beat expectations on Wednesday, January 27, 2021 with fourth quarter EPS of $1.45 on revenue of $10.7B, compared to forecast for EPS of $1.35 on revenue of $9.94B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar